Antipsychotics · Second-Generation (Atypical)

Cariprazine

Brand: Vraylar

Second-generation (atypical) antipsychotic / D3-preferring partial agonist

7 cards

Want adaptive tracking?

Create a free account and every review is tracked with spaced repetition. Cards you struggle with come back sooner, and your weak areas surface automatically.

Create free account →

Card Topics

core (3)trap (2)risk (1)dosing (1)

All Cards

1.Cariprazine: unique receptor profile.

2.Cariprazine: ultra-long active metabolite and clinical consequence.

3.You stop cariprazine. How long do effects persist?

4.Most common side effect of cariprazine.

5.Cariprazine dose range.

6.A patient on cariprazine 3mg for 5 days has no improvement. Should you increase the dose?

7.Cariprazine FDA indications.

Want the full clinical reference for this medication?

Read the Cariprazine reference page →